4
Changes in Ownership
CHAMPIONS ONCOLOGY, INC. Filed Acc 0001628280-26-004381
Options or other derivatives
- CEO acquired 700,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brainin Robert Lawrence CEO | 2025-07-16 | Grant or award · Option to purchase Common Stock | +225,000 | $7.80 | $1,755,000 | 299,163 | D |
| Brainin Robert Lawrence CEO | 2025-07-16 | Grant or award · Option to purchase Common Stock | +62,500 | $7.80 | $487,500 | 361,663 | D |
| Brainin Robert Lawrence CEO | 2025-07-16 | Grant or award · Option to purchase Common Stock | +62,500 | $7.80 | $487,500 | 424,163 | D |
| Brainin Robert Lawrence CEO | 2025-07-16 | Grant or award · Option to purchase Common Stock | +150,000 | $7.80 | $1,170,000 | 574,163 | D |
| Brainin Robert Lawrence CEO | 2025-07-16 | Grant or award · Option to purchase Common Stock | +100,000 | $7.80 | $780,000 | 674,163 | D |
| Brainin Robert Lawrence CEO | 2025-07-16 | Grant or award · Option to purchase Common Stock | +100,000 | $7.80 | $780,000 | 774,163 | D |
Loading xslF345X05/wk-form4_1769806532.xml…